1 Beaten-Down Stock to Buy Right Now, and 1 to Avoid
Equity markets are full of bargains -- stocks that have performed terribly in recent months, whether due to trade-related marketwide issues or company-specific troubles, but could bounce back once things improve. There are also companies that are not performing well and are unlikely to rebound anytime soon; that's the kind investors should stay away from.Let's consider one stock in each category: Moderna (NASDAQ: MRNA), a beaten-down stock with decent prospects, and Teladoc Health (NYSE: TDOC), one whose future looks dim.Image source: Getty Images.Continue reading
Equity markets are full of bargains -- stocks that have performed terribly in recent months, whether due to trade-related marketwide issues or company-specific troubles, but could bounce back once things improve. There are also companies that are not performing well and are unlikely to rebound anytime soon; that's the kind investors should stay away from.
Let's consider one stock in each category: Moderna (NASDAQ: MRNA), a beaten-down stock with decent prospects, and Teladoc Health (NYSE: TDOC), one whose future looks dim.
Image source: Getty Images.
